Daniel Abdun-Nabi - 06 Aug 2025 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
Director
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
Issuer symbol
APVO
Transactions as of
06 Aug 2025
Net transactions value
$0
Form type
4
Filing time
08 Aug 2025, 16:36:41 UTC
Previous filing
21 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Abdun-Nabi Daniel Director 2401 4TH AVENUE, SUITE 1050, SEATTLE /s/ SoYoung Kwon, Attorney-in-Fact 08 Aug 2025 0001380187

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Restricted Stock Unit Award $0 +7,200 $0.000000 7,200 06 Aug 2025 Common Stock 7,200 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2 The RSUs vest in full on the first anniversary of the date of grant.